Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle
Journal of the American Chemical Society · 2024
DOI: 10.1021/jacs.3c13224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2024. Verfasst von Le Tu und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Green Pesticide, International Joint Research Center for Intelligent Biosensor Technology and Health, College of Chemistry…. Hauptthemen laut MEDLINE: Ruthenium, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 130-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Science and Engineering Research Board, National Research Foundation of Korea, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Green Pesticide, International Joint Research Center for Intelligent Biosensor Technology and Health, College of Chemistry, Central China Normal University, Wuhan 430079, China.
- State Key Laboratory of Chemo/Biosensing and Chemometrics, Hunan University, Changsha 410082, China.
- Department of Chemistry, Korea University, Seoul 02841, Korea.
- Amity School of Chemical Sciences, Amity University Punjab, Sector 82A, Mohali, Punjab 140306, India.
ORCID-Profile: Amit Sharma, Junrong Li, Jong Seung Kim, Yao Sun
Förderung
- Science and Engineering Research Board
- National Research Foundation of Korea
- Department of Biotechnology, Ministry of Science and Technology, India
- Natural Science Foundation of Hubei Province
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Tu, L., Li, C., Ding, Q., Sharma, A., Li, M., Li, J., Kim, J. S., & Sun, Y. (2024). Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.3c13224
Vancouver
Tu L, Li C, Ding Q, Sharma A, Li M, Li J, et al. Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle. Journal of the American Chemical Society. 2024. doi:10.1021/jacs.3c13224
BibTeX
@article{Tu2024,
author = {Tu, Le and Li, Chonglu and Ding, Qihang and Sharma, Amit and Li, Meiqin and Li, Junrong and Kim, Jong Seung and Sun, Yao},
title = {Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle},
journal = {Journal of the American Chemical Society},
year = {2024},
doi = {10.1021/jacs.3c13224}
}
EUVIMED